News

  • Legislative Update For Week Ending February 15 2013

    Congress is now back in session but they will not begin considering new legislation for a few days. They are in the process of organizing for a new session and, of course, they will be involved in the electoral college process of electing a new President starting, but perhaps not concluding, on Wednesday. .What are the Notch Reform bills that are in the current Congress? .While TSCL supports this first legislative step, more work will be needed in the years ahead to provide greater financial certainty for disabled Social Security recipients. What do you think about the recent legislation and fixes for Social Security disability? Take TSCL's 2016 Senior Survey. … Continued

  • Legislative Update March 2011 Advisor

    In addition to drug manufacturers, major business groups and 32 conservative organizations to his actions and have been lobbying The President to change his mind. .Much of the debate over federal deficit reduction plans has been focused on overhauling Medicare and making changes to Social Security. But a major funding change is also under consideration for Medicaid, the federal and state program that covers medical care for lower-income individuals including seniors who also receive Medicare. As federal and state governments struggle to address Medicaid funding shortfalls, TSCL is concerned that Notch Babies, and the families who provide care for them, would be among those who would be hit the hardest by funding cuts. .Congress is now back in session but they will not begin considering new legislation for a few days. They are in the process of organizing for a new session and, of course, they will be involved in the electoral college process of electing a new President starting, but perhaps not concluding, on Wednesday. … Continued

The legislation would provide a ,000 settlement payable in four annual installments of ,250 or an improved monthly benefit for Notch Babies born 1917 through 1926 or survivors who receive benefits on their account. .Two Cosponsors Sign on to Key Bill .On Wednesday, President Donald Trump signed two bills – the Know the Lowest Price Act (S. 2553) and the Patient Right to Know Drug Prices Act (S. 2554) – into law that will protect Medicare beneficiaries and privately insured individuals from "gag clauses" at pharmacies. "Gag clauses" prevent pharmacists from telling consumers when it would be cheaper to purchase their prescriptions out-of-pocket than through their Medicare Part D or health insurance plans. .We need to focus on putting the "Security" back into Social Security, and providing real relief from rising Medicare costs, by avoiding double digit premium increases to begin with. Congress can accomplish both by providing an emergency COLA in 202That one action would negate the need for any Medicare Part B premium cost shifting and double-digit premium increases. Providing a benefit boost would also reduce the need to adjust Part B premiums for those with the lowest benefits in the future. .Sen. Barbara Mikulski (MD), chair of the Senate Appropriations Committee, stated earlier this week, "What I hope to be able to do is keep the government open, to avoid a government shutdown, to do no harm, and to be as boring as possible." The House planned to vote on a package that would simply extend current funding levels through mid-December on Thursday, and the Senate was set on taking it up next week. .This week, lawmakers in the Senate adopted a budget resolution that lays the groundwork for a repeal of the Affordable Care Act. In addition, The Senior Citizens League (TSCL) announced its support for three new bills in Congress. .TSCL strongly supports legislation that would provide a minimum COLA in years when inflation is below average — such as the Guaranteed 3% COLA Act (H.R. 991) sponsored by Representative Eliot Engel (NY-16). How are low COLAs and higher costs affecting you? Let your Members of Congress know! Call 1-844-455-0045. .What Are The Ten Fastest Growing Senior Costs? .The Biomedical Advanced Research and Development Authority, a federal agency known as BARDA, is giving Moderna up to 3 million for late-stage development of its vaccine.